Evidence map›Paper›PMID 33043083›Full record

ArticleMovement disorders clinical practice2020

Efficacy of Istradefylline for the Treatment of

Ryosuke Miyamoto, Toshitaka Kawarai, Toshiaki Takeuchi, Yuishin Izumi, Satoshi Goto, Ryuji Kaji

Open access · greenAbstract readCase Reports
In one paragraph

Article in Movement disorders clinical practice, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Scoping Review on ADCY5-Related Movement Disorders.Movement disorders clinical practice · 2023
    Article
  3. Improvement ofMovement disorders clinical practice · 2023
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ryosuke MiyamotoDepartment of Neurology Tokushima University Graduate School of Biomedical Sciences Tokushima Japan.ORCID https://orcid.org/0000-0001-6434-9541
Toshitaka KawaraiDepartment of Neurology Tokushima University Graduate School of Biomedical Sciences Tokushima Japan.ORCID https://orcid.org/0000-0002-0091-6647
Toshiaki TakeuchiDepartment of Neurology Tokushima University Graduate School of Biomedical Sciences Tokushima Japan.
Yuishin IzumiDepartment of Neurology Tokushima University Graduate School of Biomedical Sciences Tokushima Japan.
Satoshi GotoDepartment of Neurodegenerative Disorders Research Tokushima University Graduate School of Biomedical Sciences Tokushima Japan.
Ryuji KajiDepartment of Neurology Tokushima University Graduate School of Biomedical Sciences Tokushima Japan.
Tokushima University · JPNational Hospital Organization · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

View Supplementary Video 1 View Supplementary Video 2.

Indexed as

ADCY5adenosine A2A receptor antagonistdyskinesiahyperkinetic movement disorderistradefylline

Identifiers

PMID33043083
PMCPMC7533992
OpenAlexW3049448655

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.